Curve Biosciences

About:

Curve Biosciences focuses on precision medicine for chronic disease care, led by experts in biotech research.

Website: https://www.curvebio.com

Description:

Curve Biosciences is a biotechnology company focused on enhancing chronic disease care through precision medicine. With a team led by experts such as Nathan Hunkapiller, PhD, as Chief Scientific Officer, and Chuba Oyolu, PhD, as Chief Technology Officer, the company is at the forefront of research and development in the biotech field. Curve Biosciences aims to leverage scientific advancements to provide targeted solutions for chronic diseases, emphasizing the importance of precision in treatment approaches. The company operates within the biotechnology industry and is dedicated to improving patient outcomes through innovative research.

Total Funding Amount:

$17.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mountain View, California, United States

Founded Date:

2021-01-01

Contact Email:

contact(AT)curvebio.com

Founders:

Chuba Oyolu, Nathan Hunkapiller, Ritish Patnaik

Number of Employees:

1-10

Last Funding Date:

2024-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai